Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes

Serum Tenascin-C is independently associated with increased major adverse cardiovascular events and death in patients with type II diabetes

Saved in:
Bibliographic Details
Published in:Archives of cardiovascular diseases supplements Vol. 12; no. 1; p. 156
Main Authors: Gellen, B., Thorin-Trescases, N., Thorin, E., Gand, E., Sosner, P., Brishoual, S., Fraty, M., Hadjadj, S., Saulnier, P.J.
Format: Journal Article
Language:English
Published: 01-01-2020
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
ISSN:1878-6480
DOI:10.1016/j.acvdsp.2019.09.322